BioResource Becomes Distributor for
Boluoke Capsules to Treat Hypercoagulability

BioResource now distributes the Boluoke oral fibrinolytic agent for support and maintenance of healthy coagulation activity. 

Provided by Canada RNA Biochemical in Vancouver BC, Boluoke (pronounced Bo – LOHK) is a proprietary enzyme mixture containing lumbrokinase extracted from earthworms. Studies have shown Boluoke to be a potent agent for treating hypercoagulable blood states by 1) activating the plasminogen system and hydrolyzing fibrin directly; 2) lowering PAI-1, fibrinogen, ESR and C-RP levels; 3) lowering whole blood and plasma viscosity; and 4) reducing platelet aggregation. Research also showed Boluoke is more powerful than Nattokinase for fibrinolytic activity. A “What is Boluoke?” data sheet is attached.

Practitioners should consider using Boluoke in conjunction with SanPharma Mucor or Syntrion SyCircue to promote circulatory health in the body. The lumbrokinase capsules are best taken at least 30 minutes before meals to reduce the effect of gastric acid on the enzymes.

The Boluoke nutraceutical product comes in a 60-capsule bottle. Discounts are available for single purchases of 12 or more bottles.